fda warning letters glp-1 september 2025 Prescription by Algorithm: The Ethical and Legal Questions Behind Advertising Prescription Drug Freight Fraud Report,

Companies that swiftly identify and respond to these changes will position themselves for success, while those adopting a cautious wait-and-see approach may face declining sales

Currently, federal insurance programs cover Novo Nordisk's Wegovy -- one of the GLP-1s for people who are overweight and have heart disease -- but there is no medication for obesity alone covered by Medicare

Introduction When it comes to achieving lasting weight loss, finding the best online weight loss prescription can be a game-changer

Effects of weight loss interventions for adults who are obese on mortality, cardiovascular disease, and cancer: systematic review and meta-analysis

Immunogenicity of semaglutide in clinical trials was lower than for liraglutide